Clinical Trial Update: Effects of Intranasal Ketamine on Depression and Anxiety in Palliative Care Cancer Patients [EARLY_Phase 1]

View source ↗

Summary

This is an early Phase 1 clinical trial evaluating intranasal ketamine for depressive symptoms and anxiety in cancer patients receiving palliative care; the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety
• Cancer
• Major Depressive Disorder

Drugs mentioned

• Ketamine (ketamine)

Snippet

Sponsor: University of Zurich | Conditions: Depressive Symptoms Mild to Moderate in Severity, Anxiety | EARLY_Phase 1 | Status: NOT_YET_RECRUITING